Biotechnology Patent Applications on July 03 2025

Executive Summary

On July 03 2025, 25 patent applications related to Biotechnology were published, representing 0.3% of all patent applications for the day. While representing a smaller percentage, this activity indicates emerging innovation in Biotechnology.

Market Analysis

Leading Organizations

The top organizations driving Biotechnology innovation include:

Trenchant BioSystems, Inc.: 3 applications (12.0% of Biotechnology patents)
Institut Curie: 1 applications (4.0% of Biotechnology patents)
Institut National de la Santé et de la Recherche Médicale: 1 applications (4.0% of Biotechnology patents)
SHORELINE BIOSCIENCES, INC.: 1 applications (4.0% of Biotechnology patents)
SUSTAIN HOLDINGS, LLC: 1 applications (4.0% of Biotechnology patents)

These 5 organizations account for 7 applications (28.0% of all Biotechnology patents), indicating moderate concentration in the field.

Technology Deep Dive

Core Innovation Areas

Patent applications in Biotechnology encompass several key innovation areas:

Biotechnology: Core technology area
Biotech: Core technology area
Genetic Engineering: Core technology area
Crispr: Core technology area
Gene Therapy: Core technology area
Gene Editing: Core technology area
Synthetic Biology: Core technology area
Bioinformatics: Core technology area

Emerging areas include:

Genomics: Developing technology
Proteomics: Developing technology
Cell Therapy: Developing technology
Immunotherapy: Developing technology
Biologics: Developing technology

Technical Classification Analysis

The most active CPC classifications in Biotechnology include:

A61P35/00 (Antineoplastic agents): 6 applications (24.0%)
C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 4 applications (16.0%)
A61K48/0058 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 3 applications (12.0%)
C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 applications (12.0%)
C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 applications (12.0%)
G16B30/10 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY): 3 applications (12.0%)
G16B30/00 (ICT specially adapted for sequence analysis involving nucleotides or amino acids): 3 applications (12.0%)
A61K35/17 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 applications (8.0%)
A61K40/11 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 applications (8.0%)
A61K40/31 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 applications (8.0%)

Global Innovation Landscape

Innovation in Biotechnology spans multiple countries:

US: 67 inventors (68.4%)
KR: 14 inventors (14.3%)
ES: 4 inventors (4.1%)
CN: 3 inventors (3.1%)
FR: 2 inventors (2.0%)
SE: 2 inventors (2.0%)
CH: 2 inventors (2.0%)
DE: 2 inventors (2.0%)
GB: 1 inventors (1.0%)
VE: 1 inventors (1.0%)

The United States accounts for 68.4% of inventors in Biotechnology, indicating strong domestic innovation leadership.

Industry Collaborations

Notable collaborations in Biotechnology include:

Institut Curie × Institut National de la Santé et de la Recherche Médicale: 1 joint applications
The Broad Institute, Inc. × Massachusetts Institute of Technology: 1 joint applications
The Broad Institute, Inc. × President and Fellows of Harvard College: 1 joint applications
Massachusetts Institute of Technology × President and Fellows of Harvard College: 1 joint applications
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. × Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz: 1 joint applications

These collaborations represent 5 joint applications, indicating strong industry cooperation in Biotechnology.

Leading Inventors

Key inventors driving Biotechnology innovation:

Jonathan Ellis: 3 applications
Philip H. Coelho: 2 applications
Paul Getchel: 2 applications
Benjamin T. Edmundson: 2 applications
Samuel G. Miller: 2 applications
Duncan MacGregor: 2 applications
Michael S. Wilk: 2 applications
Joël Bodenmann: 2 applications
Pieter Van Rooyen: 2 applications
Michael Ruehle: 2 applications

Recent Patent Applications

Representative Biotechnology patent applications from July 03 2025:

20250213614. Modified RELA Protein for Inducing Interferon Expression and Engineered Immune Cells with Improved Interferon Expression

Applicant: Institut Curie, Institut National de la Santé et de la Recherche Médicale

Abstract: The invention is in the field of immunotherapy. The present application provides modified RELA protein which are useful for inducing or promoting interferon expression by immune cells, in particular T...

20250213615. CHIMERIC ANTIGEN RECEPTORS FOR NATURAL KILLER CELLS AND USES THEREOF IN IMMUNOTHERAPY

Applicant: SHORELINE BIOSCIENCES, INC.

Abstract: Provided are natural killer cells engineered to express a chimeric antigen receptor (CAR) with Toll/interleukin-1 (IL-1) receptor (TIR) signaling domains, such as a Toll-like receptor (TLR) signaling ...

20250213641. COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF

Applicant: SUSTAIN HOLDINGS, LLC

Abstract: The present invention is in the fields of medicinal chemistry, biotechnology and pharmaceuticals. The invention provides compositions comprising one or more collagen mimetic peptides, optionally attac...

20250213689. IMMUNOGENIC COMPOSITION FOR THE TREATMENT OF CANCER

Applicant: APGEN THERAPUETICS AB

Abstract: The invention relates to the field of immunotherapy, more in particular to a composition for use in the treatment of cancer. The invention also relates to a composition obtainable by such a method, su...

20250213695. ULTRASOUND-MEDIATED GENE THERAPY FOR DEEP VEIN THROMBOSIS AND POST-THROMBOTIC SYNDROME

Applicant: Cedars-Sinai Medical Center

Abstract: Systems and methods are provided for ultrasound-based microbubble-assisted or nanobubble-assisted theragnosis, treating, ameliorating, or preventing one or more vascular diseases. In particular, syste...

Market Implications

Innovation Intensity

The 25 applications indicate strong innovation activity in Biotechnology, reflecting sustained R&D investment and market development.

Competitive Landscape

Innovation in Biotechnology involves 28 organizations, indicating a highly competitive and diverse landscape with many players investing in R&D.

Technology Outlook

Emerging themes in Biotechnology patents include: cells, cell, methods, that, cancer, suggesting future development in these areas.

The current patent activity level suggests Biotechnology is in a early development phase with emerging applications and technologies.

Related Technology Areas

Innovation in Biotechnology often intersects with other emerging technologies:

Augmented Reality: 7256 applications
Semiconductors: 1504 applications
Medical Devices: 235 applications
5G Technology: 177 applications
Generative AI: 115 applications
Renewable Energy: 95 applications
Autonomous Vehicles: 86 applications
Cybersecurity: 76 applications

Biotechnology patent applications on 2025-07-03